← Back to Search

COVID-19 Booster & Flu Shot Bundle for Vaccine Uptake

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week after getting the text message
Awards & highlights

Study Summary

This trial tests whether text reminders and bundling COVID and flu vaccines can increase vaccine take-up rates.

Who is the study for?
This trial is for adults aged 18 or older who have completed their initial COVID-19 vaccine series and haven't had a booster in at least two months. Participants must be eligible for the updated booster, have not scheduled or received it yet, and need to have an SMS-capable phone number with UCLA Health.Check my eligibility
What is being tested?
The study tests if text reminders can boost the rate of people getting their bivalent COVID-19 booster shot. It also checks if suggesting bundling the flu shot with the COVID-19 booster in one appointment increases uptake of both vaccines.See study design
What are the potential side effects?
While this trial focuses on communication strategies rather than vaccine effects, typical side effects from these vaccines may include sore arm, fatigue, fever, headache, muscle pain, chills, and joint pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week after getting the text message
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week after getting the text message for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
booster take-up at UCLA/CVS in 2 weeks
booster take-up at UCLA/CVS in 4 weeks
Secondary outcome measures
Flu vaccine take-up at UCLA/CVS in 2 weeks
Influenza virus vaccine
Influenza virus vaccine
+4 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Simple ReminderExperimental Treatment1 Intervention
Group II: Flu Tag AlongExperimental Treatment2 Interventions
Group III: Covid-19 Booster + Flu BundleExperimental Treatment2 Interventions
Group IV: HoldoutActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,528 Previous Clinical Trials
10,179,851 Total Patients Enrolled
21 Trials studying COVID-19
776,604 Patients Enrolled for COVID-19

Media Library

Flu Tag Along Clinical Trial Eligibility Overview. Trial Name: NCT05586165 — N/A
COVID-19 Research Study Groups: Flu Tag Along, Simple Reminder, Covid-19 Booster + Flu Bundle, Holdout
COVID-19 Clinical Trial 2023: Flu Tag Along Highlights & Side Effects. Trial Name: NCT05586165 — N/A
Flu Tag Along 2023 Treatment Timeline for Medical Study. Trial Name: NCT05586165 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the intended outcome of this experiment?

"The primary clinical trial assessment of this study, taking place over a 2 week period following the delivery of text messages, is to evaluate the efficacy in boosting take-up at UCLA/CVS within 4 weeks. Secondary objectives include determining link click rates 1 week post message receipt and flu vaccine uptake at UCLA/CVS after 4 weeks as well as booster take-up 2 weeks from initial contact via CAIR."

Answered by AI

Is it still possible to enroll in the trial?

"Affirmative. According to clinicaltrials.gov, the trial is actively seeking out participants and was uploaded on October 18th 2022 with its last update being November 4th 2022. 97000 people are required from a single medical centre for the study's completion."

Answered by AI

What is the scope of this study in terms of participants?

"Yes, clinicaltrials.gov confirms that this medical research program is actively enrolling patients as of November 4th 2022. This endeavor was made public on October 18th and seeks 97000 participants at a single centre."

Answered by AI

Who else is applying?

What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
3+
What site did they apply to?
UCLA Health Department of Medicine, Quality Office
Recent research and studies
clinicaltrials.govStudy
Effects of Prompt to Bundle COVID-19 Booster and Flu Shot
Jeffrey T. Fujimoto, MD 2022. "Effects of Prompt to Bundle COVID-19 Booster and Flu Shot". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05586165.
~38800 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top